DIPBORN was developed by a team of important clinical and molecular geneticists, pediatricians and scientists with experience in pediatric genetic conditions. This test was carefully designed to provide accurate and useful results, based on years of research and clinical experience in molecular diagnosis. DIIPBORN met strict criteria, including
 
 
Analytical validity, or how accurately a test can detect a certain genetic change (or variant). All DNA samples for DIPBORN are analyzed in our CLIA-certified laboratory using advanced DNA sequencing technology that is> 95% accurate.
 
 
 
Clinical validity, or how well a genetic test can predict a certain disease. DIPBORN only detects highly penetrating genetic changes. This means that if someone is born with genetic changes evaluated by this test, there is a high probability (> 80%) of developing symptoms of the associated disease.
 
 
 
Clinical utility, or if a genetic test provides useful information that can help improve treatment options or other health care decisions. DIPBORN only detects conditions that can be treated * with medications, diet modification or other therapies.​